Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sovaldi
Sovaldi
Gilead offers rare apology to payers over the hep C drug sticker shock
Endpoints
Thu, 12/8/16 - 10:06 am
Gilead Sciences
drug pricing
Pharma CEOs
Sovaldi
John Milligan
What puts a new drug launch in line for victory? Ask Gilead, Biogen and J&J
Fierce Pharma
Thu, 11/17/16 - 10:01 am
Gilead Sciences
Biogen
JNJ
drug launches
AbbVie
Sovaldi
Imbruvica
Tecfidera
Unfazed by FDA Warning, Gilead Sciences' Stock Could Be Turning a Corner
Motley Fool
Sat, 10/29/16 - 01:19 pm
FDA
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Gilead May Lose Sovaldi’s European Patent
Investopedia
Fri, 10/7/16 - 10:25 pm
Gilead Sciences
Sovaldi
Europe
patents
hepatitis C
How Gilead Dominates the HCV Space
Market Realist
Mon, 09/26/16 - 09:50 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Gilead Sciences: Are Hepatitis C Sales Getting Better?
Barron's
Fri, 09/23/16 - 10:13 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Gilead to get attorney fees in hepatitis C patent fight with Merck
Yahoo/Reuters
Thu, 08/11/16 - 11:35 pm
Gilead Sciences
Merck
hepatitis C
Sovaldi
Harvoni
As hep C sales decline, Wall Street wonders what Gilead does for its next act
Stat
Wed, 07/27/16 - 09:49 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
3 Potential Stock-Moving Drug Events In The Second Half Of 2016
Investors.com
Fri, 07/1/16 - 10:07 am
Eli Lilly
solanezumab
Alzheimer's disease
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Epclusa
Sanofi
Regeneron
Praluent
Gilead Sciences, Inc: Uptick in New HCV Scripts Does Not Signal a Good Quarter
Bidness, ETC
Sat, 06/18/16 - 09:18 am
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
Gilead Sciences: A ‘Strong Uptick’ in New Hepatitis C Prescriptions
Barron's
Fri, 06/17/16 - 12:16 pm
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Will Gilead (GILD) Stock Be Helped by Hepatitis C Drug Patents Case Win?
TheStreet.com
Thu, 06/9/16 - 09:47 am
Gilead Sciences
Merck
patents
hepatitis C
Harvoni
Sovaldi
Gilead won’t have to pay $200 million in patent case because Merck lawyer lied
Stat
Wed, 06/8/16 - 09:38 am
Gilead Sciences
patents
Merck
hepatitis C
Sovaldi
Harvoni
Washington Ordered to Cover Hepatitis C Drugs During Lawsuit
Bloomberg
Fri, 05/27/16 - 10:54 pm
hepatitis C
Washington
Medicaid
Harvoni
Sovaldi
Gilead Sciences
Gilead Sciences’ Big Growth Opportunity for 2016 Is HCV
Yahoo/Market Realist
Thu, 05/19/16 - 09:41 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Behind Gilead Sciences’ Pricing Pressures for HCV Drugs in the US
Yahoo/Market Realist
Thu, 05/12/16 - 09:47 am
Gilead Sciences
hepatitis C
drug pricing
Harvoni
Sovaldi
India awards Gilead patent for Sovaldi, disappointing civic groups
Fierce Pharma
Tue, 05/10/16 - 10:28 am
India
Gilead Sciences
Sovaldi
Gilead Judge Re-Opens Case Amid Claim Merck Scientist Lied
Bloomberg
Sat, 04/30/16 - 10:41 am
Gilead Sciences
Merck
hepatitis C
Harvoni
Sovaldi
Merck's 'no patient left behind' approach to hepatitis C
BioPharma Dive
Mon, 04/18/16 - 09:00 pm
Merck
hepatitis C
Zepatier
Gilead Sciences
Sovaldi
Harvoni
This is the most expensive drug in America
Marketwatch
Thu, 04/14/16 - 09:22 pm
Gilead Sciences
Sovaldi
drug pricing
hepatitis C
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »